μ-opioid receptor-mediated depression of the hypothalamic hypocretin/orexin arousal system

Journal of Neuroscience

Volumn 28, Issue 11, 2008, Pages 2814-2819

  Li, Ying ^a   Van Den Pol, Anthony N ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Drug abuse; Hypocretin; Lateral hypothalamus; Opiate; Orexin

Indexed keywords

DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLARGINYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; METENKEPHALIN; MORPHINE; NALOXONE; OREXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AROUSAL; ARTICLE; CALCIUM CURRENT; COGNITION; CONTROLLED STUDY; DEPRESSION; HYPERPOLARIZATION; HYPOTHALAMUS; MOUSE; NERVE CELL; NERVE ENDING; NERVE EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; SPIKE WAVE;

ANIMALS; AROUSAL; EXCITATORY POSTSYNAPTIC POTENTIALS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LONG-TERM SYNAPTIC DEPRESSION; MICE; MICE, TRANSGENIC; MORPHINE; NARCOTIC ANTAGONISTS; NEUROPEPTIDES; RECEPTORS, OPIOID, MU; STREET DRUGS; SWINE;

EID: 40849138082     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5447-07.2008     Document Type: Article

References (23)

1. Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A (2006) Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49:589-601.
2. Cazala P, Darracq C, Saint-Marc M (1987) Self-administration of morphine into the lateral hypothalamus in the mouse. Brain Res 416:283-288.
3. Desjardins GC, Brawer JR, Beaudet A (1990) Distribution of mu, delta, and kappa opioid receptors in the hypothalamus of the rat. Brain Res 536:114-123.
4. Fallon JH, Leslie FM (1986) Distribution of dynorphin and enkephalin peptides in the rat brain. J Comp Neurol 249:293-336.
5. Gao XB, van den Pol AN (1999) NT-3 potentiates excitatory GABAergic synaptic transmission in cultured developing hypothalamic neurons of the rat. J Physiol (Lond) 518:81-95.
6. Georgescu D, Zachariou V, Barrot M, Mieda M, Willie JT, Eisch AJ, Yanagisawa M, Nestler EJ, DiLeone RJ (2003) Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 23:3106-3111.
7. Harris GC, Wimmer M, Jones GA (2005) A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437:556-559.
8. Huang H, Acuna-Goycolea C, Li Y, Cheng HM, Obrietan K, van den Pol AN (2007) Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: implications for cannabinoid actions on food intake and cognitive arousal. J Neurosci 27:4870-4881.
9. Lambe EK, Aghajanian GK (2003) Hypocretin (orexin) induces calcium transients in single spines postsynaptic to identified thalamocortical boutons in prefrontal slice. Neuron 40:139-150.
10. Lane-Ladd SB, Pineda J, Boundy VA, Pfeuffer T, Krupinski J, Aghajanian GK, Nestler EJ (1997) CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci 17:7890-7901.
11. Lestang I, Cardo B, Roy MT, Velley L (1985) Electrical self-stimulation deficits in the anterior and posterior parts of the medial forebrain bundle after ibotenic acid lesion of the middle lateral hypothalamus. Neuroscience 15:379-388.
12. Li Y, van den Pol AN (2006) Differential target dependent actions of coexpressed inhibitory dynorphin and excitatory hypocretin/orexin neuropeptides. J Neurosci 26:13037-13047.
13. Li Y, Gao XB, Sakurai T, van den Pol AN (2002) Hypocretin/orexin excites hypocretin neurons via a local glutamate neuron - a potential mechanism for orchestrating the hypothalamic arousal system. Neuron 36:1169-1181.
14. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1988) Anatomy of CNS opioid receptors. Trends Neurosci 11:308-314.
15. Narita M, Nagumo Y, Hashimoto S, Narita M, Khotib J, Miyatake M, Sakurai T, Yanagisawa M, Nakamachi T, Shioda S, Suzuki T (2006) Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 26:398-405.
16. Nassif S, Cardo B, Libersat F, Velley L (1985) Comparison of deficits in electrical self-stimulation after ibotenic acid lesion of the lateral hypothalamus and the medial prefrontal cortex. Brain Res 332:247-257.
17. Nestler EJ, Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278:58-63.
18. Pan YX, Xu J, Bolan E, Moskowitz HS, Xu M, Pasternak GW (2005) Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing. Mol Pharmacol 68:866-875.
19. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18:9996-10015.
20. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, et al. (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6:991-997.
21. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469-474.
22. Wise RA (2002) Brain reward circuitry: insights from unsensed incentives. Neuron 36:229-240.
23. Zhou Y, Bendor J, Hofmann L, Randesi M, Ho A, Kreek MJ (2006) Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal. J Endocrinol 191:137-145.